Literature DB >> 10781096

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.

L C Serpell1, J Berriman, R Jakes, M Goedert, R A Crowther.   

Abstract

Filamentous inclusions made of alpha-synuclein constitute the defining neuropathological characteristic of Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Rare familial cases of Parkinson's disease are associated with mutations A53T and A30P in alpha-synuclein. We report here the assembly properties and secondary structure characteristics of recombinant alpha-synuclein. Carboxy-terminally truncated human alpha-synuclein (1-87) and (1-120) showed the fastest rates of assembly, followed by human A53T alpha-synuclein, and rat and zebra finch alpha-synuclein. Wild-type human alpha-synuclein and the A30P mutant showed slower rates of assembly. Upon shaking, filaments formed within 48 h at 37 degrees C. The related proteins beta- and gamma-synuclein only assembled after several weeks of incubation. Synthetic human alpha-synuclein filaments were decorated by an antibody directed against the carboxy-terminal 10 amino acids of alpha-synuclein, as were filaments extracted from dementia with Lewy bodies and multiple system atrophy brains. Circular dichroism spectroscopy indicated that alpha-synuclein undergoes a conformational change from random coil to beta-sheet structure during assembly. X-ray diffraction and electron diffraction of the alpha-synuclein assemblies showed a cross-beta conformation characteristic of amyloid.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781096      PMCID: PMC18329          DOI: 10.1073/pnas.97.9.4897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity.

Authors:  M G Zagorski; J Yang; H Shao; K Ma; H Zeng; A Hong
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.

Authors:  K A Conway; S J Lee; J C Rochet; T T Ding; R E Williamson; P T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Straight and paired helical filaments in Alzheimer disease have a common structural unit.

Authors:  R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

4.  Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein.

Authors:  R Jakes; R A Crowther; V M Lee; J Q Trojanowski; T Iwatsubo; M Goedert
Journal:  Neurosci Lett       Date:  1999-07-02       Impact factor: 3.046

5.  "Cross-beta" conformation in proteins.

Authors:  A J Geddes; K D Parker; E D Atkins; E Beighton
Journal:  J Mol Biol       Date:  1968-03-14       Impact factor: 5.469

6.  X-ray diffraction studies on amyloid filaments.

Authors:  E D Eanes; G G Glenner
Journal:  J Histochem Cytochem       Date:  1968-11       Impact factor: 2.479

7.  Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components.

Authors:  W P Gai; J H Power; P C Blumbergs; J G Culvenor; P H Jensen
Journal:  J Neurochem       Date:  1999-11       Impact factor: 5.372

8.  Lewy bodies in cerebral cortex, report of three cases.

Authors:  K Kosaka
Journal:  Acta Neuropathol       Date:  1978-05-24       Impact factor: 17.088

9.  Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

Authors:  C Hilbich; B Kisters-Woike; J Reed; C L Masters; K Beyreuther
Journal:  J Mol Biol       Date:  1991-03-05       Impact factor: 5.469

10.  Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.

Authors:  D A Kirschner; H Inouye; L K Duffy; A Sinclair; M Lind; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

View more
  253 in total

1.  Three-dimensional structure of the lithostathine protofibril, a protein involved in Alzheimer's disease.

Authors:  C Grégoire; S Marco; J Thimonier; L Duplan; E Laurine; J P Chauvin; B Michel; V Peyrot; J M Verdier
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model.

Authors:  P J Kahle; M Neumann; L Ozmen; V Müller; S Odoy; N Okamoto; H Jacobsen; T Iwatsubo; J Q Trojanowski; H Takahashi; K Wakabayashi; N Bogdanovic; P Riederer; H A Kretzschmar; C Haass
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 3.  Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions.

Authors:  Arthur Horwich
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

Authors:  N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

5.  SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease.

Authors:  Pablo Garcia-Reitböck; Oleg Anichtchik; Arianna Bellucci; Mariangela Iovino; Chiara Ballini; Elena Fineberg; Bernardino Ghetti; Laura Della Corte; PierFranco Spano; George K Tofaris; Michel Goedert; Maria Grazia Spillantini
Journal:  Brain       Date:  2010-06-09       Impact factor: 13.501

6.  The protofilament structure of insulin amyloid fibrils.

Authors:  José L Jiménez; Ewan J Nettleton; Mario Bouchard; Carol V Robinson; Christopher M Dobson; Helen R Saibil
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

7.  Polyglutamine fibrillogenesis: the pathway unfolds.

Authors:  Christopher A Ross; Michelle A Poirier; Erich E Wanker; Mario Amzel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-30       Impact factor: 11.205

Review 8.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

9.  The effect of truncation on prion-like properties of α-synuclein.

Authors:  Makoto Terada; Genjiro Suzuki; Takashi Nonaka; Fuyuki Kametani; Akira Tamaoka; Masato Hasegawa
Journal:  J Biol Chem       Date:  2018-07-20       Impact factor: 5.157

10.  Helix periodicity, topology, and dynamics of membrane-associated alpha-synuclein.

Authors:  Robert Bussell; Trudy Fiona Ramlall; David Eliezer
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.